Showing results (481-490 of 686) with videos related to

Sort By:
Pageof 69
Gut|December 3, 2005
Functional dyspepsia, delayed gastric emptying, and impaired quality of lifeN J Talley, G R Locke, B D Lahr, et al.
Neurogastroenterology and Motility|May 3, 2016
Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI studyA Rubio, S Pellissier, L Van Oudenhove, et al.
Clinical Immunology (Orlando, Fla.)|June 16, 2015
One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitusEdwin J P van Asseldonk, Pleun C M van Poppel, Dov B Ballak, et al.
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
New algorithm for the treatment of gastro-oesophageal reflux diseaseG N Tytgat, K McColl, J Tack, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patientsE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux diseaseJ M Conchillo, M P Schwartz, M Selimah, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetesE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Pageof 69